Precigen (PGEN) Cash from Operations (2012 - 2026)
Precigen's (PGEN) quarterly Cash from Operations came in at 43827000.0 in Q1 2026, down 168.47% year-on-year from 64013221.35 in Q1 2025, and down 86.82% on a QoQ basis from 23460000.0 in Q4 2025.
Precigen (PGEN) Cash from Operations (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Cash from Operations data on file, last reported at 43827000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 168.47% year-over-year to 43827000.0 in Q1 2026; TTM through Mar 2026 was 115333000.0, a 63.81% decrease from a year earlier, with the FY2025 full-year figure at 87831000.0, down 28.84% from the prior year.
- Cash from Operations for Q1 2026 stood at 43827000.0, down from 23460000.0 in the prior quarter.
- Over the last five years, Cash from Operations for PGEN reached as high as 7053000.0 in Q2 2022 and fell as low as 43827000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 19518000.0 across 5 years, with a median of 18388000.0 in 2023.
- Across the five-year window, Cash from Operations jumped 47.72% in 2024 and sank 184.61% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 15396000.0 in 2022, then declined by 2.4% to 15766000.0 in 2023, then soared by 47.72% to 8243000.0 in 2024, then sank by 184.61% to 23460000.0 in 2025, then plunged by 86.82% to 43827000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 43827000.0 in Q1 2026, 23460000.0 in Q4 2025, and 29069000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -43.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.83 Mn |
| Mar 31, 2026 | -43.83 Mn |
| Dec 31, 2025 | -23.46 Mn |
| Dec 31, 2025 | -23.46 Mn |
| Sep 30, 2025 | -29.07 Mn |
| Sep 30, 2025 | -29.07 Mn |
| Jun 30, 2025 | -18.98 Mn |
| Jun 30, 2025 | -18.98 Mn |
| Mar 31, 2025 | -16.33 Mn |
| Mar 31, 2025 | -16.33 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Sep 30, 2024 | -22.73 Mn |
| Sep 30, 2024 | -22.73 Mn |
| Jun 30, 2024 | -23.11 Mn |
| Jun 30, 2024 | -23.11 Mn |
| Mar 31, 2024 | -14.09 Mn |
| Mar 31, 2024 | -14.09 Mn |
| Dec 31, 2023 | -15.77 Mn |
| Dec 31, 2023 | -15.77 Mn |